We establish that CD4+ T cells are the primary cells driving meta-inflammation via TNF-α in T2DM patients through STAT3 and provide an inclusive characterization of chronic low-grade inflammation in T2DM patients. Here, TNF is linked to type 2 diabetes mellitus.